![](https://investorshub.advfn.com/uicon/29747.png?cb=1464811254)
Saturday, May 25, 2024 9:50:15 AM
Recent BIAF News
- bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests • Business Wire • 06/12/2024 12:00:00 PM
- bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes • Business Wire • 05/15/2024 01:15:00 PM
- bioAffinity Technologies News Update • Business Wire • 05/02/2024 12:00:00 PM
- bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth • Business Wire • 04/24/2024 12:00:00 PM
- bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening • Business Wire • 04/09/2024 12:00:00 PM
- bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 04/01/2024 01:49:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:00:45 PM
- Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement • PR Newswire (US) • 03/08/2024 06:15:00 PM
- bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement • Business Wire • 03/08/2024 05:45:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/08/2024 05:18:40 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/08/2024 02:57:51 AM
- WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement • PR Newswire (US) • 03/06/2024 03:45:00 PM
- bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement • Business Wire • 03/06/2024 02:46:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 10:26:46 PM
- bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung • Business Wire • 03/05/2024 01:00:00 PM
- bioAffinity Technologies News Update • Business Wire • 02/21/2024 01:00:00 PM
- Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice • Business Wire • 02/06/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:25:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:22:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:21:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:17:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:05:25 PM
- bioAffinity Technologies In The News • Business Wire • 01/30/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 01:52:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 01:52:35 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM